Form 4: Inhibrx Biosciences Director Vuori Acquires 7,140 Shares of Common Stock
SEC Form 4
Kristiina Vuori, a director of Inhibrx Biosciences, purchased 7,140 shares of common stock at $14 per share on August 29, 2024.
Summary
- On August 29, 2024, Kristiina Vuori, a director of Inhibrx Biosciences, Inc., acquired 7,140 shares of common stock.
- The purchase price was $14 per share.
- Following the transaction, Ms. Vuori directly owns 7,140 shares of Inhibrx Biosciences, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Director stock purchases are common and closely watched as indicators of management's sentiment about the company's prospects. This purchase could be interpreted as a positive signal.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/29/2024 | Date of transaction: Kristiina Vuori purchased 7,140 shares of common stock. |
| 09/03/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.